A Midwestern trial site organization has been at the forefront of conducting vaccine clinical trials during the pandemic on behalf of contract research organizations (CROs)…
Vaccine developer Novavax, Inc. (Nasdaq: NVAX) recently announced the publication of results from the final analysis of a pivotal Phase 3 clinical trial of its COVID-19…
Article 1 | UK-based Meta Analysis Peer Reviewed & Published Suggests Ivermectin A Key Public Health Weapon in the War Against COVID-19:Recently published in the…
U.S-based Novavax (Nasdaq: NVAX) reports today that its COVID-19 vaccine candidate called NVX-CoV2373 or “Coronavax” demonstrated 100% protection against moderate and severe disease and 90.4%…
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it has initiated a pediatric expansion of its…
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced its participation in a newly expanded investigator-initiated Phase 2…
Novavax Inc. (Nasdaq: NVAX) inked a Memorandum of Understanding (MOU) with Gavi, the Vaccine Alliance (Gavi), to supply up to 1.1 billion cumulative doses of…
Military and connected beneficiaries of Fort Bragg’s Military Health System and Tricare can lend a hand to help the biomedical research necessary to get another…
Affiliated with Brown University, Rhode Island Hospitals and Health Services also known as Lifespan now seeks to enroll volunteers for the Phase 3 Novavax COVID-19…
One of the first physician/investigators to distribute the Novavax vaccine in the recently launched Phase 3 clinical trial was showcased via Utah’s KUTV recently as…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
